“I have seen first hand how abiraterone has changed people’s lives; not only the men living with metastatic prostate cancer, but their partners and families as well,” says Dr. Lori Wood, Medical Oncologist, Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia. “This treatment can dramatically improve the quality of life of these men with very little, if any, side effects, and also helps them live longer.”
Dr. Kara Laing, President, Canadian Association of Medical Oncologists and Clinical Chief, Cancer Care Program, feels the same way about Abiraterone (Zytiga).
“So many of our patients have benefited from abiraterone and we have seen significant improvements in their health. As a physician, it’s exciting to now have this option available for our patients in Canada
No comments:
Post a Comment